Cargando…

mRNA therapeutics: New vaccination and beyond

The idea of mRNA therapy had been conceived for decades before it came into reality during the Covid-19 pandemic. The mRNA vaccine emerges as a powerful and general tool against new viral infections, largely due to its versatility and rapid development. In addition to prophylactic vaccines, mRNA tec...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Huan-Huan, Zheng, Liangliang, Wang, Zefeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Publishing Services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10017382/
http://dx.doi.org/10.1016/j.fmre.2023.02.022
_version_ 1784907569845764096
author Wei, Huan-Huan
Zheng, Liangliang
Wang, Zefeng
author_facet Wei, Huan-Huan
Zheng, Liangliang
Wang, Zefeng
author_sort Wei, Huan-Huan
collection PubMed
description The idea of mRNA therapy had been conceived for decades before it came into reality during the Covid-19 pandemic. The mRNA vaccine emerges as a powerful and general tool against new viral infections, largely due to its versatility and rapid development. In addition to prophylactic vaccines, mRNA technology also offers great promise for new applications as a versatile drug modality. However, realizing the conceptual potential faces considerable challenges, such as minimal immune stimulation, high and long-term expression, and efficient delivery to target cells and tissues. Here we review the applications of mRNA-based therapeutics, with emphasis on the innovative design and future challenges/solutions. In addition, we also discuss the next generation of mRNA therapy, including circular mRNA and self-amplifying RNAs. We aim to provide a conceptual overview and outlook on mRNA therapeutics beyond prophylactic vaccines.
format Online
Article
Text
id pubmed-10017382
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher The Authors. Publishing Services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd.
record_format MEDLINE/PubMed
spelling pubmed-100173822023-03-16 mRNA therapeutics: New vaccination and beyond Wei, Huan-Huan Zheng, Liangliang Wang, Zefeng Fundamental Research Review The idea of mRNA therapy had been conceived for decades before it came into reality during the Covid-19 pandemic. The mRNA vaccine emerges as a powerful and general tool against new viral infections, largely due to its versatility and rapid development. In addition to prophylactic vaccines, mRNA technology also offers great promise for new applications as a versatile drug modality. However, realizing the conceptual potential faces considerable challenges, such as minimal immune stimulation, high and long-term expression, and efficient delivery to target cells and tissues. Here we review the applications of mRNA-based therapeutics, with emphasis on the innovative design and future challenges/solutions. In addition, we also discuss the next generation of mRNA therapy, including circular mRNA and self-amplifying RNAs. We aim to provide a conceptual overview and outlook on mRNA therapeutics beyond prophylactic vaccines. The Authors. Publishing Services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd. 2023-03-16 /pmc/articles/PMC10017382/ http://dx.doi.org/10.1016/j.fmre.2023.02.022 Text en © 2023 The Authors. Publishing Services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Review
Wei, Huan-Huan
Zheng, Liangliang
Wang, Zefeng
mRNA therapeutics: New vaccination and beyond
title mRNA therapeutics: New vaccination and beyond
title_full mRNA therapeutics: New vaccination and beyond
title_fullStr mRNA therapeutics: New vaccination and beyond
title_full_unstemmed mRNA therapeutics: New vaccination and beyond
title_short mRNA therapeutics: New vaccination and beyond
title_sort mrna therapeutics: new vaccination and beyond
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10017382/
http://dx.doi.org/10.1016/j.fmre.2023.02.022
work_keys_str_mv AT weihuanhuan mrnatherapeuticsnewvaccinationandbeyond
AT zhengliangliang mrnatherapeuticsnewvaccinationandbeyond
AT wangzefeng mrnatherapeuticsnewvaccinationandbeyond